IBDEI0JZ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9005,1,3,0)
 ;;=3^Mitochondrial metabolism disorder, unspecified
 ;;^UTILITY(U,$J,358.3,9005,1,4,0)
 ;;=4^E88.40
 ;;^UTILITY(U,$J,358.3,9005,2)
 ;;=^5003030
 ;;^UTILITY(U,$J,358.3,9006,0)
 ;;=E88.41^^55^556^72
 ;;^UTILITY(U,$J,358.3,9006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9006,1,3,0)
 ;;=3^MELAS syndrome
 ;;^UTILITY(U,$J,358.3,9006,1,4,0)
 ;;=4^E88.41
 ;;^UTILITY(U,$J,358.3,9006,2)
 ;;=^278244
 ;;^UTILITY(U,$J,358.3,9007,0)
 ;;=E88.42^^55^556^73
 ;;^UTILITY(U,$J,358.3,9007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9007,1,3,0)
 ;;=3^MERRF syndrome
 ;;^UTILITY(U,$J,358.3,9007,1,4,0)
 ;;=4^E88.42
 ;;^UTILITY(U,$J,358.3,9007,2)
 ;;=^278246
 ;;^UTILITY(U,$J,358.3,9008,0)
 ;;=E88.49^^55^556^79
 ;;^UTILITY(U,$J,358.3,9008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9008,1,3,0)
 ;;=3^Mitochondrial metabolism disorders NEC
 ;;^UTILITY(U,$J,358.3,9008,1,4,0)
 ;;=4^E88.49
 ;;^UTILITY(U,$J,358.3,9008,2)
 ;;=^5003031
 ;;^UTILITY(U,$J,358.3,9009,0)
 ;;=H49.819^^55^556^63
 ;;^UTILITY(U,$J,358.3,9009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9009,1,3,0)
 ;;=3^Kearns-Sayre syndrome, unspecified eye
 ;;^UTILITY(U,$J,358.3,9009,1,4,0)
 ;;=4^H49.819
 ;;^UTILITY(U,$J,358.3,9009,2)
 ;;=^5006202
 ;;^UTILITY(U,$J,358.3,9010,0)
 ;;=E66.9^^55^556^85
 ;;^UTILITY(U,$J,358.3,9010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9010,1,3,0)
 ;;=3^Obesity, unspecified
 ;;^UTILITY(U,$J,358.3,9010,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,9010,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,9011,0)
 ;;=E66.01^^55^556^81
 ;;^UTILITY(U,$J,358.3,9011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9011,1,3,0)
 ;;=3^Morbid (severe) obesity due to excess calories
 ;;^UTILITY(U,$J,358.3,9011,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,9011,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,9012,0)
 ;;=F51.02^^55^556^10
 ;;^UTILITY(U,$J,358.3,9012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9012,1,3,0)
 ;;=3^Adjustment insomnia
 ;;^UTILITY(U,$J,358.3,9012,1,4,0)
 ;;=4^F51.02
 ;;^UTILITY(U,$J,358.3,9012,2)
 ;;=^5003604
 ;;^UTILITY(U,$J,358.3,9013,0)
 ;;=F32.9^^55^556^74
 ;;^UTILITY(U,$J,358.3,9013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9013,1,3,0)
 ;;=3^Major depressive disorder, single episode, unspecified
 ;;^UTILITY(U,$J,358.3,9013,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,9013,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,9014,0)
 ;;=H53.9^^55^556^111
 ;;^UTILITY(U,$J,358.3,9014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9014,1,3,0)
 ;;=3^Visual Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,9014,1,4,0)
 ;;=4^H53.9
 ;;^UTILITY(U,$J,358.3,9014,2)
 ;;=^124001
 ;;^UTILITY(U,$J,358.3,9015,0)
 ;;=H91.91^^55^556^53
 ;;^UTILITY(U,$J,358.3,9015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9015,1,3,0)
 ;;=3^Hearing Loss,Right Ear,Unspec
 ;;^UTILITY(U,$J,358.3,9015,1,4,0)
 ;;=4^H91.91
 ;;^UTILITY(U,$J,358.3,9015,2)
 ;;=^5133553
 ;;^UTILITY(U,$J,358.3,9016,0)
 ;;=H91.92^^55^556^52
 ;;^UTILITY(U,$J,358.3,9016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9016,1,3,0)
 ;;=3^Hearing Loss,Left Ear,Unspec
 ;;^UTILITY(U,$J,358.3,9016,1,4,0)
 ;;=4^H91.92
 ;;^UTILITY(U,$J,358.3,9016,2)
 ;;=^5133554
 ;;^UTILITY(U,$J,358.3,9017,0)
 ;;=H91.93^^55^556^51
 ;;^UTILITY(U,$J,358.3,9017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9017,1,3,0)
 ;;=3^Hearing Loss,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,9017,1,4,0)
 ;;=4^H91.93
 ;;^UTILITY(U,$J,358.3,9017,2)
 ;;=^5006944
 ;;^UTILITY(U,$J,358.3,9018,0)
 ;;=I08.0^^55^556^98
 ;;^UTILITY(U,$J,358.3,9018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9018,1,3,0)
 ;;=3^Rheumatic disorders of both mitral and aortic valves
